Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge

Autor: Leonardo Régis Leira Pereira, Osvaldo de Freitas, Angela Achcar, Thais Rodrigues Penaforte, Maurílio de Souza Cazarim
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
lcsh:Medicine
Blood Pressure
Disease
030204 cardiovascular system & hematology
Pharmacists
Vascular Medicine
Biochemistry
030226 pharmacology & pharmacy
0302 clinical medicine
Risk Factors
Outcome Assessment
Health Care

Medicine and Health Sciences
lcsh:Science
Multidisciplinary
Pharmaceutics
Drugs
Middle Aged
After discharge
Professions
Antihypertensive Drugs
Cholesterol
Health Education and Awareness
Cardiovascular Diseases
Hypertension
Female
Risk assessment
Brazil
Research Article
Adult
medicine.medical_specialty
Lipoproteins
Risk Assessment
03 medical and health sciences
Pharmacotherapy
Drug Therapy
medicine
Humans
cardiovascular diseases
Intensive care medicine
Primary Care
Antihypertensive Agents
Triglycerides
Retrospective Studies
Pharmacology
Impact assessment
business.industry
Cholesterol
HDL

lcsh:R
Biology and Life Sciences
Proteins
Reproducibility of Results
Retrospective cohort study
Cholesterol
LDL

nervous system diseases
Health Care
DOENÇAS CARDIOVASCULARES
Pharmaceutical care
Blood pressure
Pharmaceutical Services
People and Places
Population Groupings
lcsh:Q
business
Follow-Up Studies
Program Evaluation
Zdroj: PLoS ONE, Vol 11, Iss 6, p e0155204 (2016)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
PLoS ONE
ISSN: 1932-6203
Popis: Introduction Almost 50% of the 17.5 million deaths worldwide from cardiovascular disease have been associated with systemic arterial hypertension (SAH). Into this scenario, Pharmaceutical Care (PC) has been inserted in order to improve the management of SAH and reduce its risks. Objective To evaluate the outcomes and healthcare assistance achieved after discharge of hypertension patients from the PC program. Methods This is a quasi-experimental study with historical controls. Retrospective data collection from 2006 to 2012 was begun in 2013 and included a PC program performed over one year. PC was performed in two basic units of the public health system in Ribeirão Preto-SP, Brazil, where the pharmacist followed up 104 hypertensive patients. The clinical indicators of systolic (SBP) and diastolic blood pressure (DBP), triglycerides, total-cholesterol, high and low density lipoprotein cholesterol were collected, as well as care indicators related to the number of consultations (basic, specialized and emergency care) and antihypertensive drugs used. The coronary risk of patients by the Framingham risk score was also calculated. For the analysis, the data were divided into three periods, 2006–2008 as pre-PC, 2009 as PC and 2010–2012 as post-PC. Results In the pre-PC period, 54.4%, 79.0% and 27.3% of patients presented satisfactory levels of SBP, DBP and total-cholesterol, respectively. In the post-PC period, the percentages were 93.0% for SBP and DBP [p
Databáze: OpenAIRE